[1] 乔友林, 赵宇倩. 宫颈癌的流行病学现状和预防[J].中华妇幼临床医学杂志(电子版), 2015, 11(2):1-6. [2] 刘植华, 李悦, 李英勇.子宫颈癌的早期诊断[J].中国实用妇科与产科杂志, 2004, 20(7): 435-436. [3] Partridge EE,Abu-Rustum N,Giuliano A,et al.Cervical cancer screening[J].Natl Compr Canc Netw,2014,12 (3) :333-341. [4] Kitamura H, Motohashi H. NRF2 addiction in cancer cells[J].Cancer Sci,2018, 109(4):900-911. [5] Meng X, Sun G, Ye J, et al. Notoginsenoside R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1/2 pathways: A novel mechanism of Nrf2/ARE signaling activation[J].Free Radic Res,2014, 48(4): 445-460. [6] Zhang DD. The Nrf2-Keap1-ARE signaling pathway: the regulation and dual function of Nrf2 in cancer[J].Antioxid Redox Signal,2010, 13(11): 1623-1626. [7] Saw C L L, Yang A Y, Guo Y, et al. Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway[J].Food Chem Toxicol,2013, 62: 869-875. [8] Lau A, Villeneuve NF, Sun Z, et al. Dual roles of Nrf2 in cancer[J].Pharmacol Res,2008, 58(5-6):262-270. [9] Krajkaku niak V, Paluszczak J, Baerdubowska W. The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment [J].Pharmacol Rep,2016, 69(3):393-402. [10] Pandey P, Singh A K, Singh M, et al. The see-saw of Keap1-Nrf2 pathway in cancer[J].Crit Rev Oncol Hematol,2017, 116:89-98. [11] 张文芳, 潘春燕, 张印星. mTOR/P70S6K 信号通路在宫颈癌组织中的表达及其临床意义[J].解放军医药杂志, 2015, 27(4): 5.
2019, Vol. 36 
